Last Friday, it even made a new 52-week high of Rs 64.90, on reports that Rakesh Jhunjhunwala, known as India’s Warren Buffett, bought 10 million shares (about 1.3 per cent stake) worth Rs 55 crore in the company via open market deals. The rising investor interest is not surprising, as the company is placed well to gain from improving activity in the capital markets, as well as economic revival.
Unlike some peers, Edelweiss, a leading brokerage player, has successfully diversified into other financial service segments. Most of these are earning a healthy return on equity. Foreign institutional investors collectively held 39 per cent stake in Edelweiss as of March 31 — including Carlyle, the government of Singapore, Fidelity and Sequoia Capital — and this, too, provides confidence.
“Our long-term strategy of diversifying across businesses, asset classes and client segments continues to stand us in good stead. Increasingly, our profits are being contributed by multiple businesses and we have reduced concentration risk in our efforts to make the profits more sustainable,” said Rashesh Shah, chairman and chief executive, after its FY14 results.
While its brokerage business is doing fairly well compared to peers, the diversification is likely to boost growth further. The balance sheet has grown and so have profits. Consolidated net profit was up from Rs 128 crore in FY12 to Rs 178 crore in FY13 and Rs 220 crore in FY14. This has been aided by a focus on quality and profitable growth across businesses.
Analysts expect the business to grow by a little more than 20 per cent annually over the next two years (driven by housing and loans against property) and the lending business to contribute significantly to Edelweiss’ financials. A focus on retail loans, which have been growing fast, should help on profits, too.
Though its life insurance business (six per cent of revenue) is making a loss of Rs 17 crore every quarter, analysts expect it to turn around over the next two years. The rest of the revenue comes from treasury and commodities (14-15 per cent each).
At Rs 62.35, the stock trades at 16.5 times the FY15 estimated earnings and appears fairly valued. Investors with a long-term perspective can consider it on corrections.